In this podcast, Steven Grinspoon, MD, discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD. More at: www.consultant360.com/gastroenterology